FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200462608> ?p ?o ?g. }

• W3200462608 endingPage "276" @default.
• W3200462608 startingPage "267" @default.
• W3200462608 abstract "We conducted this study to describe detailed the clinical characteristics, ancillary test results and treatment response of a group of Chinese patients with anti-IgLON5 disease.We recruited 13 patients with positive IgLON5 antibodies in serum and/or cerebrospinal fluid from nine tertiary referral centers. Patients were enrolled from February 2017 to July 2021. We retrospectively collected information on the presenting and main symptoms, treatment response and follow-up outcomes.The median age of onset for symptoms was 60 (range: 33-73) years and six of the 13 patients were females. The predominant clinical presentations included sleep disturbance (eight patients) and cognitive impairment (seven patients), followed by movement disorders (six patients). Parainfectious cause seemed plausible. Notably, we identified the first case of possible Epstein-Barr virus (EBV)-related anti-IgLON5 disease. Coexisting neural autoantibodies were identified in two patients. Furthermore, two patients had other autoimmune diseases. The IgG subclass was determined in four patients, including two with dominant IgG4 subtype and two with dominant IgG1 subtype. Additionally, 10 patients were treated with immunotherapy and four patients exhibited improvement. Overall, six of 10 patients for whom follow-up results were assessable had favorable clinical outcomes (modified Rankin Scale score ≤2).The clinical spectrum of anti-IgLON5 disease is variable. Our results highlight a boarder spectrum of anti-IgLON5 disease." @default.
• W3200462608 created "2021-09-27" @default.
• W3200462608 creator A5001002958 @default.
• W3200462608 creator A5007768670 @default.
• W3200462608 creator A5008008791 @default.
• W3200462608 creator A5009766909 @default.
• W3200462608 creator A5011333342 @default.
• W3200462608 creator A5012521371 @default.
• W3200462608 creator A5013832419 @default.
• W3200462608 creator A5017327555 @default.
• W3200462608 creator A5021946429 @default.
• W3200462608 creator A5031804038 @default.
• W3200462608 creator A5032839141 @default.
• W3200462608 creator A5040329361 @default.
• W3200462608 creator A5041966023 @default.
• W3200462608 creator A5042973046 @default.
• W3200462608 creator A5044780583 @default.
• W3200462608 creator A5046221264 @default.
• W3200462608 creator A5052134746 @default.
• W3200462608 creator A5053885203 @default.
• W3200462608 creator A5059057094 @default.
• W3200462608 creator A5069153972 @default.
• W3200462608 creator A5081924740 @default.
• W3200462608 creator A5081925414 @default.
• W3200462608 creator A5087047119 @default.
• W3200462608 creator A5091718254 @default.
• W3200462608 date "2021-10-03" @default.
• W3200462608 modified "2023-10-17" @default.
• W3200462608 title "Expanding the clinical spectrum of anti‐IgLON5 disease: A multicenter retrospective study" @default.
• W3200462608 cites W2008134500 @default.
• W3200462608 cites W2101252880 @default.
• W3200462608 cites W2473655507 @default.
• W3200462608 cites W2514674077 @default.
• W3200462608 cites W2605154961 @default.
• W3200462608 cites W2608662968 @default.
• W3200462608 cites W2736610570 @default.
• W3200462608 cites W2795909823 @default.
• W3200462608 cites W2800919983 @default.
• W3200462608 cites W2808530095 @default.
• W3200462608 cites W2811271149 @default.
• W3200462608 cites W2883022707 @default.
• W3200462608 cites W2913461658 @default.
• W3200462608 cites W2945869590 @default.
• W3200462608 cites W2980350220 @default.
• W3200462608 cites W2986564491 @default.
• W3200462608 cites W2995203051 @default.
• W3200462608 cites W2995881671 @default.
• W3200462608 cites W3009649114 @default.
• W3200462608 cites W3126901498 @default.
• W3200462608 cites W3126988135 @default.
• W3200462608 cites W3129098364 @default.
• W3200462608 cites W3139420840 @default.
• W3200462608 doi "https://doi.org/10.1111/ene.15117" @default.
• W3200462608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34543501" @default.
• W3200462608 hasPublicationYear "2021" @default.
• W3200462608 type Work @default.
• W3200462608 sameAs 3200462608 @default.
• W3200462608 citedByCount "18" @default.
• W3200462608 countsByYear W32004626082022 @default.
• W3200462608 countsByYear W32004626082023 @default.
• W3200462608 crossrefType "journal-article" @default.
• W3200462608 hasAuthorship W3200462608A5001002958 @default.
• W3200462608 hasAuthorship W3200462608A5007768670 @default.
• W3200462608 hasAuthorship W3200462608A5008008791 @default.
• W3200462608 hasAuthorship W3200462608A5009766909 @default.
• W3200462608 hasAuthorship W3200462608A5011333342 @default.
• W3200462608 hasAuthorship W3200462608A5012521371 @default.
• W3200462608 hasAuthorship W3200462608A5013832419 @default.
• W3200462608 hasAuthorship W3200462608A5017327555 @default.
• W3200462608 hasAuthorship W3200462608A5021946429 @default.
• W3200462608 hasAuthorship W3200462608A5031804038 @default.
• W3200462608 hasAuthorship W3200462608A5032839141 @default.
• W3200462608 hasAuthorship W3200462608A5040329361 @default.
• W3200462608 hasAuthorship W3200462608A5041966023 @default.
• W3200462608 hasAuthorship W3200462608A5042973046 @default.
• W3200462608 hasAuthorship W3200462608A5044780583 @default.
• W3200462608 hasAuthorship W3200462608A5046221264 @default.
• W3200462608 hasAuthorship W3200462608A5052134746 @default.
• W3200462608 hasAuthorship W3200462608A5053885203 @default.
• W3200462608 hasAuthorship W3200462608A5059057094 @default.
• W3200462608 hasAuthorship W3200462608A5069153972 @default.
• W3200462608 hasAuthorship W3200462608A5081924740 @default.
• W3200462608 hasAuthorship W3200462608A5081925414 @default.
• W3200462608 hasAuthorship W3200462608A5087047119 @default.
• W3200462608 hasAuthorship W3200462608A5091718254 @default.
• W3200462608 hasConcept C126322002 @default.
• W3200462608 hasConcept C167135981 @default.
• W3200462608 hasConcept C187212893 @default.
• W3200462608 hasConcept C2779134260 @default.
• W3200462608 hasConcept C71924100 @default.
• W3200462608 hasConceptScore W3200462608C126322002 @default.
• W3200462608 hasConceptScore W3200462608C167135981 @default.
• W3200462608 hasConceptScore W3200462608C187212893 @default.
• W3200462608 hasConceptScore W3200462608C2779134260 @default.
• W3200462608 hasConceptScore W3200462608C71924100 @default.
• W3200462608 hasIssue "1" @default.
• W3200462608 hasLocation W32004626081 @default.
• W3200462608 hasLocation W32004626082 @default.

• next